nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A4—Rivastigmine—Alzheimer's disease	0.153	0.432	CbGbCtD
Rivaroxaban—CYP3A4—Donepezil—Alzheimer's disease	0.122	0.345	CbGbCtD
Rivaroxaban—CYP3A4—Galantamine—Alzheimer's disease	0.0789	0.223	CbGbCtD
Rivaroxaban—Linezolid—MAOB—Alzheimer's disease	0.0157	1	CrCbGaD
Rivaroxaban—CYP2J2—blood vessel—Alzheimer's disease	0.00494	0.257	CbGeAlD
Rivaroxaban—Haematoma—Rivastigmine—Alzheimer's disease	0.00382	0.00873	CcSEcCtD
Rivaroxaban—Blister—Rivastigmine—Alzheimer's disease	0.00333	0.00762	CcSEcCtD
Rivaroxaban—Haemoptysis—Memantine—Alzheimer's disease	0.00332	0.00758	CcSEcCtD
Rivaroxaban—Blood urea increased—Galantamine—Alzheimer's disease	0.0033	0.00753	CcSEcCtD
Rivaroxaban—Dermatitis atopic—Rivastigmine—Alzheimer's disease	0.00325	0.00742	CcSEcCtD
Rivaroxaban—Contusion—Donepezil—Alzheimer's disease	0.0031	0.00708	CcSEcCtD
Rivaroxaban—Rectal haemorrhage—Donepezil—Alzheimer's disease	0.003	0.00684	CcSEcCtD
Rivaroxaban—Myocardial ischaemia—Rivastigmine—Alzheimer's disease	0.00299	0.00683	CcSEcCtD
Rivaroxaban—Gamma-glutamyltransferase increased—Memantine—Alzheimer's disease	0.00299	0.00682	CcSEcCtD
Rivaroxaban—Oropharyngeal pain—Donepezil—Alzheimer's disease	0.00298	0.0068	CcSEcCtD
Rivaroxaban—Pallor—Memantine—Alzheimer's disease	0.00296	0.00677	CcSEcCtD
Rivaroxaban—Pallor—Rivastigmine—Alzheimer's disease	0.0029	0.00662	CcSEcCtD
Rivaroxaban—Rectal haemorrhage—Memantine—Alzheimer's disease	0.00272	0.00621	CcSEcCtD
Rivaroxaban—Rectal haemorrhage—Rivastigmine—Alzheimer's disease	0.00266	0.00608	CcSEcCtD
Rivaroxaban—CYP2J2—forebrain—Alzheimer's disease	0.00261	0.135	CbGeAlD
Rivaroxaban—Blood urea increased—Donepezil—Alzheimer's disease	0.00255	0.00583	CcSEcCtD
Rivaroxaban—Pain in extremity—Galantamine—Alzheimer's disease	0.00253	0.00579	CcSEcCtD
Rivaroxaban—Ecchymosis—Donepezil—Alzheimer's disease	0.00245	0.00559	CcSEcCtD
Rivaroxaban—CYP2J2—telencephalon—Alzheimer's disease	0.0024	0.125	CbGeAlD
Rivaroxaban—Blood urea increased—Memantine—Alzheimer's disease	0.00232	0.0053	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00231	0.00529	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Donepezil—Alzheimer's disease	0.00206	0.00469	CcSEcCtD
Rivaroxaban—Hepatic function abnormal—Memantine—Alzheimer's disease	0.00204	0.00466	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.00196	0.00449	CcSEcCtD
Rivaroxaban—Osteoarthritis—Donepezil—Alzheimer's disease	0.00196	0.00449	CcSEcCtD
Rivaroxaban—Renal failure acute—Memantine—Alzheimer's disease	0.00193	0.00441	CcSEcCtD
Rivaroxaban—Renal failure—Galantamine—Alzheimer's disease	0.00192	0.00438	CcSEcCtD
Rivaroxaban—Urinary tract infection—Galantamine—Alzheimer's disease	0.0019	0.00434	CcSEcCtD
Rivaroxaban—Renal failure acute—Rivastigmine—Alzheimer's disease	0.00189	0.00432	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Memantine—Alzheimer's disease	0.00187	0.00426	CcSEcCtD
Rivaroxaban—Haematuria—Galantamine—Alzheimer's disease	0.00186	0.00425	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00185	0.00422	CcSEcCtD
Rivaroxaban—Epistaxis—Galantamine—Alzheimer's disease	0.00184	0.00421	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Donepezil—Alzheimer's disease	0.00184	0.0042	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Rivastigmine—Alzheimer's disease	0.00183	0.00417	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Donepezil—Alzheimer's disease	0.00179	0.0041	CcSEcCtD
Rivaroxaban—Pain in extremity—Memantine—Alzheimer's disease	0.00178	0.00407	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.00178	0.00407	CcSEcCtD
Rivaroxaban—Osteoarthritis—Memantine—Alzheimer's disease	0.00178	0.00407	CcSEcCtD
Rivaroxaban—Haemoglobin—Galantamine—Alzheimer's disease	0.00176	0.00402	CcSEcCtD
Rivaroxaban—Haemorrhage—Galantamine—Alzheimer's disease	0.00175	0.004	CcSEcCtD
Rivaroxaban—Hepatitis—Galantamine—Alzheimer's disease	0.00175	0.004	CcSEcCtD
Rivaroxaban—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00174	0.00398	CcSEcCtD
Rivaroxaban—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.00174	0.00398	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.00174	0.00398	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00173	0.00395	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00172	0.00394	CcSEcCtD
Rivaroxaban—Urethral disorder—Galantamine—Alzheimer's disease	0.00172	0.00393	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Memantine—Alzheimer's disease	0.00167	0.00382	CcSEcCtD
Rivaroxaban—Angina pectoris—Donepezil—Alzheimer's disease	0.00165	0.00378	CcSEcCtD
Rivaroxaban—Eye disorder—Galantamine—Alzheimer's disease	0.00164	0.00374	CcSEcCtD
Rivaroxaban—Cardiac disorder—Galantamine—Alzheimer's disease	0.00163	0.00372	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.00159	0.00364	CcSEcCtD
Rivaroxaban—Angiopathy—Galantamine—Alzheimer's disease	0.00159	0.00363	CcSEcCtD
Rivaroxaban—Immune system disorder—Galantamine—Alzheimer's disease	0.00158	0.00362	CcSEcCtD
Rivaroxaban—Infestation NOS—Donepezil—Alzheimer's disease	0.00151	0.00346	CcSEcCtD
Rivaroxaban—Infestation—Donepezil—Alzheimer's disease	0.00151	0.00346	CcSEcCtD
Rivaroxaban—Angina pectoris—Memantine—Alzheimer's disease	0.0015	0.00343	CcSEcCtD
Rivaroxaban—Renal failure—Donepezil—Alzheimer's disease	0.00149	0.0034	CcSEcCtD
Rivaroxaban—Back pain—Galantamine—Alzheimer's disease	0.00148	0.00337	CcSEcCtD
Rivaroxaban—Jaundice—Donepezil—Alzheimer's disease	0.00148	0.00337	CcSEcCtD
Rivaroxaban—Urinary tract infection—Donepezil—Alzheimer's disease	0.00147	0.00336	CcSEcCtD
Rivaroxaban—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00147	0.00335	CcSEcCtD
Rivaroxaban—Muscle spasms—Galantamine—Alzheimer's disease	0.00147	0.00335	CcSEcCtD
Rivaroxaban—Haematuria—Donepezil—Alzheimer's disease	0.00144	0.0033	CcSEcCtD
Rivaroxaban—Epistaxis—Donepezil—Alzheimer's disease	0.00143	0.00326	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00142	0.00323	CcSEcCtD
Rivaroxaban—CYP2J2—nervous system—Alzheimer's disease	0.00141	0.0735	CbGeAlD
Rivaroxaban—Anaemia—Galantamine—Alzheimer's disease	0.00141	0.00322	CcSEcCtD
Rivaroxaban—Malaise—Galantamine—Alzheimer's disease	0.00138	0.00314	CcSEcCtD
Rivaroxaban—Infestation NOS—Memantine—Alzheimer's disease	0.00137	0.00314	CcSEcCtD
Rivaroxaban—Infestation—Memantine—Alzheimer's disease	0.00137	0.00314	CcSEcCtD
Rivaroxaban—Syncope—Galantamine—Alzheimer's disease	0.00137	0.00313	CcSEcCtD
Rivaroxaban—Haemoglobin—Donepezil—Alzheimer's disease	0.00137	0.00312	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00136	0.00311	CcSEcCtD
Rivaroxaban—CYP2J2—central nervous system—Alzheimer's disease	0.00136	0.0708	CbGeAlD
Rivaroxaban—Haemorrhage—Donepezil—Alzheimer's disease	0.00136	0.0031	CcSEcCtD
Rivaroxaban—Hepatitis—Donepezil—Alzheimer's disease	0.00136	0.0031	CcSEcCtD
Rivaroxaban—Renal failure—Memantine—Alzheimer's disease	0.00135	0.00309	CcSEcCtD
Rivaroxaban—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00134	0.00307	CcSEcCtD
Rivaroxaban—Infestation—Rivastigmine—Alzheimer's disease	0.00134	0.00307	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00134	0.00306	CcSEcCtD
Rivaroxaban—Loss of consciousness—Galantamine—Alzheimer's disease	0.00134	0.00306	CcSEcCtD
Rivaroxaban—Urinary tract infection—Memantine—Alzheimer's disease	0.00134	0.00305	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.00133	0.00304	CcSEcCtD
Rivaroxaban—Urethral disorder—Donepezil—Alzheimer's disease	0.00133	0.00304	CcSEcCtD
Rivaroxaban—CYP2J2—cerebellum—Alzheimer's disease	0.00133	0.0692	CbGeAlD
Rivaroxaban—Renal failure—Rivastigmine—Alzheimer's disease	0.00132	0.00302	CcSEcCtD
Rivaroxaban—Haematuria—Memantine—Alzheimer's disease	0.00131	0.00299	CcSEcCtD
Rivaroxaban—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00131	0.00298	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Memantine—Alzheimer's disease	0.0013	0.00297	CcSEcCtD
Rivaroxaban—Chest pain—Galantamine—Alzheimer's disease	0.0013	0.00297	CcSEcCtD
Rivaroxaban—Epistaxis—Memantine—Alzheimer's disease	0.0013	0.00296	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00129	0.00295	CcSEcCtD
Rivaroxaban—Sinusitis—Memantine—Alzheimer's disease	0.00129	0.00294	CcSEcCtD
Rivaroxaban—Discomfort—Galantamine—Alzheimer's disease	0.00128	0.00293	CcSEcCtD
Rivaroxaban—Agranulocytosis—Memantine—Alzheimer's disease	0.00128	0.00293	CcSEcCtD
Rivaroxaban—Haematuria—Rivastigmine—Alzheimer's disease	0.00128	0.00293	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00127	0.0029	CcSEcCtD
Rivaroxaban—Dry mouth—Galantamine—Alzheimer's disease	0.00127	0.0029	CcSEcCtD
Rivaroxaban—Epistaxis—Rivastigmine—Alzheimer's disease	0.00127	0.0029	CcSEcCtD
Rivaroxaban—Sinusitis—Rivastigmine—Alzheimer's disease	0.00126	0.00288	CcSEcCtD
Rivaroxaban—Haemoglobin—Memantine—Alzheimer's disease	0.00124	0.00283	CcSEcCtD
Rivaroxaban—Hepatitis—Memantine—Alzheimer's disease	0.00123	0.00282	CcSEcCtD
Rivaroxaban—Haemorrhage—Memantine—Alzheimer's disease	0.00123	0.00282	CcSEcCtD
Rivaroxaban—Shock—Galantamine—Alzheimer's disease	0.00123	0.0028	CcSEcCtD
Rivaroxaban—Nervous system disorder—Galantamine—Alzheimer's disease	0.00122	0.00279	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Memantine—Alzheimer's disease	0.00122	0.00278	CcSEcCtD
Rivaroxaban—Tachycardia—Galantamine—Alzheimer's disease	0.00122	0.00278	CcSEcCtD
Rivaroxaban—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00121	0.00277	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Memantine—Alzheimer's disease	0.00121	0.00277	CcSEcCtD
Rivaroxaban—Skin disorder—Galantamine—Alzheimer's disease	0.00121	0.00276	CcSEcCtD
Rivaroxaban—Urethral disorder—Memantine—Alzheimer's disease	0.00121	0.00276	CcSEcCtD
Rivaroxaban—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00121	0.00276	CcSEcCtD
Rivaroxaban—Hepatitis—Rivastigmine—Alzheimer's disease	0.00121	0.00276	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00119	0.00272	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00119	0.00271	CcSEcCtD
Rivaroxaban—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00118	0.0027	CcSEcCtD
Rivaroxaban—Erythema multiforme—Memantine—Alzheimer's disease	0.00117	0.00266	CcSEcCtD
Rivaroxaban—Hypotension—Galantamine—Alzheimer's disease	0.00116	0.00266	CcSEcCtD
Rivaroxaban—Eye disorder—Memantine—Alzheimer's disease	0.00115	0.00263	CcSEcCtD
Rivaroxaban—Cardiac disorder—Memantine—Alzheimer's disease	0.00114	0.00262	CcSEcCtD
Rivaroxaban—Back pain—Donepezil—Alzheimer's disease	0.00114	0.00261	CcSEcCtD
Rivaroxaban—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00114	0.00261	CcSEcCtD
Rivaroxaban—Muscle spasms—Donepezil—Alzheimer's disease	0.00114	0.0026	CcSEcCtD
Rivaroxaban—Eye disorder—Rivastigmine—Alzheimer's disease	0.00113	0.00258	CcSEcCtD
Rivaroxaban—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00112	0.00256	CcSEcCtD
Rivaroxaban—Angiopathy—Memantine—Alzheimer's disease	0.00112	0.00256	CcSEcCtD
Rivaroxaban—Immune system disorder—Memantine—Alzheimer's disease	0.00111	0.00255	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Memantine—Alzheimer's disease	0.00111	0.00254	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Donepezil—Alzheimer's disease	0.0011	0.00251	CcSEcCtD
Rivaroxaban—Dyspepsia—Galantamine—Alzheimer's disease	0.0011	0.0025	CcSEcCtD
Rivaroxaban—Angiopathy—Rivastigmine—Alzheimer's disease	0.0011	0.0025	CcSEcCtD
Rivaroxaban—Anaemia—Donepezil—Alzheimer's disease	0.00109	0.0025	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00109	0.00248	CcSEcCtD
Rivaroxaban—CYP2J2—brain—Alzheimer's disease	0.00108	0.0562	CbGeAlD
Rivaroxaban—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00108	0.00246	CcSEcCtD
Rivaroxaban—Fatigue—Galantamine—Alzheimer's disease	0.00107	0.00245	CcSEcCtD
Rivaroxaban—Malaise—Donepezil—Alzheimer's disease	0.00107	0.00244	CcSEcCtD
Rivaroxaban—Constipation—Galantamine—Alzheimer's disease	0.00107	0.00243	CcSEcCtD
Rivaroxaban—Syncope—Donepezil—Alzheimer's disease	0.00106	0.00242	CcSEcCtD
Rivaroxaban—Loss of consciousness—Donepezil—Alzheimer's disease	0.00104	0.00237	CcSEcCtD
Rivaroxaban—Back pain—Memantine—Alzheimer's disease	0.00104	0.00237	CcSEcCtD
Rivaroxaban—Feeling abnormal—Galantamine—Alzheimer's disease	0.00103	0.00234	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00102	0.00233	CcSEcCtD
Rivaroxaban—Back pain—Rivastigmine—Alzheimer's disease	0.00102	0.00232	CcSEcCtD
Rivaroxaban—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00101	0.00231	CcSEcCtD
Rivaroxaban—Chest pain—Donepezil—Alzheimer's disease	0.00101	0.0023	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Memantine—Alzheimer's disease	0.000996	0.00228	CcSEcCtD
Rivaroxaban—Discomfort—Donepezil—Alzheimer's disease	0.000995	0.00227	CcSEcCtD
Rivaroxaban—Anaemia—Memantine—Alzheimer's disease	0.000993	0.00227	CcSEcCtD
Rivaroxaban—Dry mouth—Donepezil—Alzheimer's disease	0.000985	0.00225	CcSEcCtD
Rivaroxaban—Abdominal pain—Galantamine—Alzheimer's disease	0.000985	0.00225	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000975	0.00223	CcSEcCtD
Rivaroxaban—Anaemia—Rivastigmine—Alzheimer's disease	0.000971	0.00222	CcSEcCtD
Rivaroxaban—Malaise—Memantine—Alzheimer's disease	0.000969	0.00221	CcSEcCtD
Rivaroxaban—Oedema—Donepezil—Alzheimer's disease	0.000965	0.0022	CcSEcCtD
Rivaroxaban—Syncope—Memantine—Alzheimer's disease	0.000963	0.0022	CcSEcCtD
Rivaroxaban—Infection—Donepezil—Alzheimer's disease	0.000959	0.00219	CcSEcCtD
Rivaroxaban—Shock—Donepezil—Alzheimer's disease	0.00095	0.00217	CcSEcCtD
Rivaroxaban—Malaise—Rivastigmine—Alzheimer's disease	0.000947	0.00216	CcSEcCtD
Rivaroxaban—Nervous system disorder—Donepezil—Alzheimer's disease	0.000947	0.00216	CcSEcCtD
Rivaroxaban—Loss of consciousness—Memantine—Alzheimer's disease	0.000944	0.00216	CcSEcCtD
Rivaroxaban—Syncope—Rivastigmine—Alzheimer's disease	0.000942	0.00215	CcSEcCtD
Rivaroxaban—ABCB1—blood vessel—Alzheimer's disease	0.000924	0.048	CbGeAlD
Rivaroxaban—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000923	0.00211	CcSEcCtD
Rivaroxaban—Hypersensitivity—Galantamine—Alzheimer's disease	0.000918	0.0021	CcSEcCtD
Rivaroxaban—Chest pain—Memantine—Alzheimer's disease	0.000914	0.00209	CcSEcCtD
Rivaroxaban—Discomfort—Memantine—Alzheimer's disease	0.000903	0.00206	CcSEcCtD
Rivaroxaban—Hypotension—Donepezil—Alzheimer's disease	0.000902	0.00206	CcSEcCtD
Rivaroxaban—Chest pain—Rivastigmine—Alzheimer's disease	0.000894	0.00204	CcSEcCtD
Rivaroxaban—Dry mouth—Memantine—Alzheimer's disease	0.000894	0.00204	CcSEcCtD
Rivaroxaban—Asthenia—Galantamine—Alzheimer's disease	0.000894	0.00204	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000888	0.00203	CcSEcCtD
Rivaroxaban—Discomfort—Rivastigmine—Alzheimer's disease	0.000884	0.00202	CcSEcCtD
Rivaroxaban—Oedema—Memantine—Alzheimer's disease	0.000877	0.002	CcSEcCtD
Rivaroxaban—Dry mouth—Rivastigmine—Alzheimer's disease	0.000875	0.002	CcSEcCtD
Rivaroxaban—Infection—Memantine—Alzheimer's disease	0.000871	0.00199	CcSEcCtD
Rivaroxaban—Shock—Memantine—Alzheimer's disease	0.000862	0.00197	CcSEcCtD
Rivaroxaban—Dyspnoea—Donepezil—Alzheimer's disease	0.000861	0.00197	CcSEcCtD
Rivaroxaban—Nervous system disorder—Memantine—Alzheimer's disease	0.00086	0.00196	CcSEcCtD
Rivaroxaban—Oedema—Rivastigmine—Alzheimer's disease	0.000857	0.00196	CcSEcCtD
Rivaroxaban—Tachycardia—Memantine—Alzheimer's disease	0.000855	0.00195	CcSEcCtD
Rivaroxaban—Diarrhoea—Galantamine—Alzheimer's disease	0.000852	0.00195	CcSEcCtD
Rivaroxaban—Infection—Rivastigmine—Alzheimer's disease	0.000852	0.00195	CcSEcCtD
Rivaroxaban—Skin disorder—Memantine—Alzheimer's disease	0.000851	0.00194	CcSEcCtD
Rivaroxaban—Dyspepsia—Donepezil—Alzheimer's disease	0.00085	0.00194	CcSEcCtD
Rivaroxaban—Shock—Rivastigmine—Alzheimer's disease	0.000844	0.00193	CcSEcCtD
Rivaroxaban—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000841	0.00192	CcSEcCtD
Rivaroxaban—Tachycardia—Rivastigmine—Alzheimer's disease	0.000837	0.00191	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000833	0.0019	CcSEcCtD
Rivaroxaban—Skin disorder—Rivastigmine—Alzheimer's disease	0.000833	0.0019	CcSEcCtD
Rivaroxaban—Fatigue—Donepezil—Alzheimer's disease	0.000832	0.0019	CcSEcCtD
Rivaroxaban—Constipation—Donepezil—Alzheimer's disease	0.000826	0.00189	CcSEcCtD
Rivaroxaban—Pain—Donepezil—Alzheimer's disease	0.000826	0.00189	CcSEcCtD
Rivaroxaban—Dizziness—Galantamine—Alzheimer's disease	0.000824	0.00188	CcSEcCtD
Rivaroxaban—Hypotension—Memantine—Alzheimer's disease	0.000819	0.00187	CcSEcCtD
Rivaroxaban—Hypotension—Rivastigmine—Alzheimer's disease	0.000801	0.00183	CcSEcCtD
Rivaroxaban—Feeling abnormal—Donepezil—Alzheimer's disease	0.000796	0.00182	CcSEcCtD
Rivaroxaban—Vomiting—Galantamine—Alzheimer's disease	0.000792	0.00181	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000789	0.0018	CcSEcCtD
Rivaroxaban—Rash—Galantamine—Alzheimer's disease	0.000785	0.00179	CcSEcCtD
Rivaroxaban—Dermatitis—Galantamine—Alzheimer's disease	0.000785	0.00179	CcSEcCtD
Rivaroxaban—Dyspnoea—Memantine—Alzheimer's disease	0.000781	0.00178	CcSEcCtD
Rivaroxaban—Headache—Galantamine—Alzheimer's disease	0.00078	0.00178	CcSEcCtD
Rivaroxaban—Dyspepsia—Memantine—Alzheimer's disease	0.000772	0.00176	CcSEcCtD
Rivaroxaban—Urticaria—Donepezil—Alzheimer's disease	0.000767	0.00175	CcSEcCtD
Rivaroxaban—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000764	0.00175	CcSEcCtD
Rivaroxaban—Abdominal pain—Donepezil—Alzheimer's disease	0.000763	0.00174	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000757	0.00173	CcSEcCtD
Rivaroxaban—Fatigue—Memantine—Alzheimer's disease	0.000756	0.00173	CcSEcCtD
Rivaroxaban—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000755	0.00172	CcSEcCtD
Rivaroxaban—Constipation—Memantine—Alzheimer's disease	0.00075	0.00171	CcSEcCtD
Rivaroxaban—Pain—Memantine—Alzheimer's disease	0.00075	0.00171	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00074	0.00169	CcSEcCtD
Rivaroxaban—Nausea—Galantamine—Alzheimer's disease	0.00074	0.00169	CcSEcCtD
Rivaroxaban—Fatigue—Rivastigmine—Alzheimer's disease	0.000739	0.00169	CcSEcCtD
Rivaroxaban—Constipation—Rivastigmine—Alzheimer's disease	0.000733	0.00167	CcSEcCtD
Rivaroxaban—Pain—Rivastigmine—Alzheimer's disease	0.000733	0.00167	CcSEcCtD
Rivaroxaban—Feeling abnormal—Memantine—Alzheimer's disease	0.000722	0.00165	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000717	0.00164	CcSEcCtD
Rivaroxaban—Hypersensitivity—Donepezil—Alzheimer's disease	0.000711	0.00162	CcSEcCtD
Rivaroxaban—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000707	0.00161	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000701	0.0016	CcSEcCtD
Rivaroxaban—Urticaria—Memantine—Alzheimer's disease	0.000696	0.00159	CcSEcCtD
Rivaroxaban—Abdominal pain—Memantine—Alzheimer's disease	0.000693	0.00158	CcSEcCtD
Rivaroxaban—Asthenia—Donepezil—Alzheimer's disease	0.000693	0.00158	CcSEcCtD
Rivaroxaban—Pruritus—Donepezil—Alzheimer's disease	0.000683	0.00156	CcSEcCtD
Rivaroxaban—Urticaria—Rivastigmine—Alzheimer's disease	0.000681	0.00156	CcSEcCtD
Rivaroxaban—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000678	0.00155	CcSEcCtD
Rivaroxaban—Diarrhoea—Donepezil—Alzheimer's disease	0.000661	0.00151	CcSEcCtD
Rivaroxaban—Hypersensitivity—Memantine—Alzheimer's disease	0.000646	0.00147	CcSEcCtD
Rivaroxaban—Dizziness—Donepezil—Alzheimer's disease	0.000638	0.00146	CcSEcCtD
Rivaroxaban—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000632	0.00144	CcSEcCtD
Rivaroxaban—Asthenia—Memantine—Alzheimer's disease	0.000629	0.00144	CcSEcCtD
Rivaroxaban—Pruritus—Memantine—Alzheimer's disease	0.00062	0.00142	CcSEcCtD
Rivaroxaban—Asthenia—Rivastigmine—Alzheimer's disease	0.000615	0.00141	CcSEcCtD
Rivaroxaban—Vomiting—Donepezil—Alzheimer's disease	0.000614	0.0014	CcSEcCtD
Rivaroxaban—Rash—Donepezil—Alzheimer's disease	0.000609	0.00139	CcSEcCtD
Rivaroxaban—Dermatitis—Donepezil—Alzheimer's disease	0.000608	0.00139	CcSEcCtD
Rivaroxaban—Pruritus—Rivastigmine—Alzheimer's disease	0.000607	0.00139	CcSEcCtD
Rivaroxaban—Headache—Donepezil—Alzheimer's disease	0.000605	0.00138	CcSEcCtD
Rivaroxaban—Diarrhoea—Memantine—Alzheimer's disease	0.0006	0.00137	CcSEcCtD
Rivaroxaban—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000587	0.00134	CcSEcCtD
Rivaroxaban—Dizziness—Memantine—Alzheimer's disease	0.00058	0.00132	CcSEcCtD
Rivaroxaban—Nausea—Donepezil—Alzheimer's disease	0.000573	0.00131	CcSEcCtD
Rivaroxaban—Dizziness—Rivastigmine—Alzheimer's disease	0.000567	0.0013	CcSEcCtD
Rivaroxaban—Vomiting—Memantine—Alzheimer's disease	0.000557	0.00127	CcSEcCtD
Rivaroxaban—Rash—Memantine—Alzheimer's disease	0.000553	0.00126	CcSEcCtD
Rivaroxaban—Dermatitis—Memantine—Alzheimer's disease	0.000552	0.00126	CcSEcCtD
Rivaroxaban—ABCB1—embryo—Alzheimer's disease	0.000551	0.0286	CbGeAlD
Rivaroxaban—Headache—Memantine—Alzheimer's disease	0.000549	0.00125	CcSEcCtD
Rivaroxaban—Vomiting—Rivastigmine—Alzheimer's disease	0.000545	0.00125	CcSEcCtD
Rivaroxaban—Rash—Rivastigmine—Alzheimer's disease	0.000541	0.00123	CcSEcCtD
Rivaroxaban—Dermatitis—Rivastigmine—Alzheimer's disease	0.00054	0.00123	CcSEcCtD
Rivaroxaban—Headache—Rivastigmine—Alzheimer's disease	0.000537	0.00123	CcSEcCtD
Rivaroxaban—Nausea—Memantine—Alzheimer's disease	0.000521	0.00119	CcSEcCtD
Rivaroxaban—Nausea—Rivastigmine—Alzheimer's disease	0.000509	0.00116	CcSEcCtD
Rivaroxaban—ABCB1—forebrain—Alzheimer's disease	0.000487	0.0253	CbGeAlD
Rivaroxaban—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000472	0.00273	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—CLU—Alzheimer's disease	0.000455	0.00263	CbGpPWpGaD
Rivaroxaban—ABCB1—telencephalon—Alzheimer's disease	0.000448	0.0233	CbGeAlD
Rivaroxaban—F10—Metabolism of proteins—ADAMTS4—Alzheimer's disease	0.000444	0.00257	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—CP—Alzheimer's disease	0.000443	0.00256	CbGpPWpGaD
Rivaroxaban—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000441	0.00256	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—DHCR24—Alzheimer's disease	0.000437	0.00253	CbGpPWpGaD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB2—Alzheimer's disease	0.000437	0.00253	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.00043	0.00249	CbGpPWpGaD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000418	0.00242	CbGpPWpGaD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.00041	0.00238	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000408	0.00236	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—A2M—Alzheimer's disease	0.000405	0.00235	CbGpPWpGaD
Rivaroxaban—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000392	0.00227	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—TF—Alzheimer's disease	0.000376	0.00218	CbGpPWpGaD
Rivaroxaban—CYP3A4—nervous system—Alzheimer's disease	0.000374	0.0194	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism—CA4—Alzheimer's disease	0.000372	0.00215	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000363	0.0021	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—MME—Alzheimer's disease	0.000362	0.0021	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—ENO1—Alzheimer's disease	0.000361	0.00209	CbGpPWpGaD
Rivaroxaban—CYP3A4—central nervous system—Alzheimer's disease	0.00036	0.0187	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism—GAPDHS—Alzheimer's disease	0.000349	0.00202	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—INPP5D—Alzheimer's disease	0.000349	0.00202	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TF—Alzheimer's disease	0.000345	0.002	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—HSPD1—Alzheimer's disease	0.000336	0.00195	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ATP5A1—Alzheimer's disease	0.000331	0.00192	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000321	0.00186	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PLD3—Alzheimer's disease	0.000316	0.00183	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000316	0.00183	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—GAB2—Alzheimer's disease	0.000315	0.00183	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000312	0.00181	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—APP—Alzheimer's disease	0.000307	0.00178	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—HSD17B10—Alzheimer's disease	0.000303	0.00175	CbGpPWpGaD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000299	0.00173	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000296	0.00172	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—MAOB—Alzheimer's disease	0.000293	0.0017	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYP46A1—Alzheimer's disease	0.000292	0.00169	CbGpPWpGaD
Rivaroxaban—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000291	0.00168	CbGpPWpGaD
Rivaroxaban—F10—Post-translational protein modification—F2—Alzheimer's disease	0.000289	0.00167	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—EIF2S1—Alzheimer's disease	0.000284	0.00165	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ND1—Alzheimer's disease	0.000282	0.00163	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—ACHE—Alzheimer's disease	0.000277	0.00161	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000275	0.00159	CbGpPWpGaD
Rivaroxaban—ABCB1—nervous system—Alzheimer's disease	0.000265	0.0137	CbGeAlD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Alzheimer's disease	0.000263	0.00152	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CTSD—Alzheimer's disease	0.000263	0.00152	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000257	0.00149	CbGpPWpGaD
Rivaroxaban—ABCB1—central nervous system—Alzheimer's disease	0.000255	0.0132	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000252	0.00146	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—SOD1—Alzheimer's disease	0.00025	0.00145	CbGpPWpGaD
Rivaroxaban—ABCB1—cerebellum—Alzheimer's disease	0.000249	0.0129	CbGeAlD
Rivaroxaban—F10—Metabolism of proteins—GSK3A—Alzheimer's disease	0.000246	0.00142	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—BCHE—Alzheimer's disease	0.000242	0.0014	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—IGF2—Alzheimer's disease	0.000238	0.00138	CbGpPWpGaD
Rivaroxaban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000235	0.00136	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—ACE—Alzheimer's disease	0.000234	0.00136	CbGpPWpGaD
Rivaroxaban—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000232	0.00135	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.000229	0.00132	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000228	0.00132	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000225	0.00131	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—PTGS1—Alzheimer's disease	0.000222	0.00129	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—CYP2D6—Alzheimer's disease	0.000218	0.00126	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000217	0.00126	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000215	0.00125	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PRKCG—Alzheimer's disease	0.000214	0.00124	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL1A—Alzheimer's disease	0.000214	0.00124	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000203	0.00118	CbGpPWpGaD
Rivaroxaban—ABCB1—brain—Alzheimer's disease	0.000202	0.0105	CbGeAlD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—LEP—Alzheimer's disease	0.000202	0.00117	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.0002	0.00116	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000198	0.00114	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000195	0.00113	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000191	0.0011	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—NOS2—Alzheimer's disease	0.000188	0.00109	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PLAU—Alzheimer's disease	0.000187	0.00109	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—IGF2—Alzheimer's disease	0.000187	0.00108	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—CALM1—Alzheimer's disease	0.000185	0.00107	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000185	0.00107	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000184	0.00107	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—CAV1—Alzheimer's disease	0.000183	0.00106	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—TPI1—Alzheimer's disease	0.000181	0.00105	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CHAT—Alzheimer's disease	0.000181	0.00105	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000179	0.00104	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—F2—Alzheimer's disease	0.000174	0.00101	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—MAOB—Alzheimer's disease	0.000174	0.00101	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—CREB1—Alzheimer's disease	0.000173	0.001	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—NOS2—Alzheimer's disease	0.000172	0.000997	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.000168	0.000971	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GAPDH—Alzheimer's disease	0.000167	0.00097	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000166	0.000959	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.000165	0.000953	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000164	0.00095	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—A2M—Alzheimer's disease	0.000162	0.000937	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—IGF1—Alzheimer's disease	0.000153	0.000884	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.000146	0.000845	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—LEP—Alzheimer's disease	0.000145	0.000842	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000144	0.000836	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000143	0.000831	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ACHE—Alzheimer's disease	0.000141	0.000815	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000141	0.000815	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—INPP5D—Alzheimer's disease	0.000139	0.000806	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—NOS3—Alzheimer's disease	0.000138	0.000802	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—F2—Alzheimer's disease	0.000137	0.000794	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	0.000136	0.00079	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS1—Alzheimer's disease	0.000132	0.000764	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ENO1—Alzheimer's disease	0.000132	0.000764	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYP2D6—Alzheimer's disease	0.000129	0.000749	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—DHCR24—Alzheimer's disease	0.000126	0.00073	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—INS—Alzheimer's disease	0.000124	0.000719	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—BCHE—Alzheimer's disease	0.000123	0.00071	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CCL2—Alzheimer's disease	0.000122	0.000708	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—IGF1—Alzheimer's disease	0.00012	0.000696	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.00012	0.000693	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PLCB1—Alzheimer's disease	0.000116	0.00067	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000113	0.000657	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ABCA1—Alzheimer's disease	0.000112	0.00065	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL1B—Alzheimer's disease	0.000111	0.000645	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CASP3—Alzheimer's disease	0.000111	0.000644	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.00011	0.000636	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	0.000109	0.000631	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CA4—Alzheimer's disease	0.000107	0.00062	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	0.000103	0.000599	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000102	0.000592	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	0.000101	0.000587	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GAPDHS—Alzheimer's disease	0.000101	0.000583	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	9.99e-05	0.000579	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—VEGFA—Alzheimer's disease	9.97e-05	0.000578	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPARGC1A—Alzheimer's disease	9.66e-05	0.00056	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—HMOX1—Alzheimer's disease	9.62e-05	0.000557	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ATP5A1—Alzheimer's disease	9.55e-05	0.000553	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—DHCR24—Alzheimer's disease	9.51e-05	0.000551	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	9.43e-05	0.000546	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TGFB1—Alzheimer's disease	9.15e-05	0.00053	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLD3—Alzheimer's disease	9.11e-05	0.000528	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—LPL—Alzheimer's disease	8.8e-05	0.00051	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HSD17B10—Alzheimer's disease	8.73e-05	0.000506	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	8.66e-05	0.000502	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP46A1—Alzheimer's disease	8.41e-05	0.000487	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	8.23e-05	0.000477	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ND1—Alzheimer's disease	8.12e-05	0.00047	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	8.09e-05	0.000468	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CA4—Alzheimer's disease	8.08e-05	0.000468	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—MTHFR—Alzheimer's disease	7.92e-05	0.000459	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	7.6e-05	0.00044	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TP53—Alzheimer's disease	7.54e-05	0.000437	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	7.51e-05	0.000435	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	7.41e-05	0.000429	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CALM1—Alzheimer's disease	7.4e-05	0.000429	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOE—Alzheimer's disease	7.38e-05	0.000427	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CAV1—Alzheimer's disease	7.31e-05	0.000423	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	7.2e-05	0.000417	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	7.13e-05	0.000413	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	6.95e-05	0.000403	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLD3—Alzheimer's disease	6.87e-05	0.000398	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	6.59e-05	0.000382	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPARG—Alzheimer's disease	6.42e-05	0.000372	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	6.39e-05	0.00037	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—AKT1—Alzheimer's disease	6.36e-05	0.000369	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	6.34e-05	0.000367	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—INS—Alzheimer's disease	6.3e-05	0.000365	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	6.22e-05	0.00036	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ND1—Alzheimer's disease	6.13e-05	0.000355	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	5.91e-05	0.000342	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	5.86e-05	0.000339	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—NOS3—Alzheimer's disease	5.53e-05	0.00032	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	5.49e-05	0.000318	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CHAT—Alzheimer's disease	5.23e-05	0.000303	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—TPI1—Alzheimer's disease	5.23e-05	0.000303	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—Alzheimer's disease	5.05e-05	0.000293	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	5.04e-05	0.000292	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MAOB—Alzheimer's disease	5.02e-05	0.000291	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CA4—Alzheimer's disease	4.98e-05	0.000288	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	4.83e-05	0.00028	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	4.68e-05	0.000271	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—A2M—Alzheimer's disease	4.66e-05	0.00027	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	4.66e-05	0.00027	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	4.47e-05	0.000259	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	4.44e-05	0.000257	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	4.27e-05	0.000248	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLD3—Alzheimer's disease	4.23e-05	0.000245	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	4.06e-05	0.000235	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ACHE—Alzheimer's disease	4.06e-05	0.000235	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	4.01e-05	0.000232	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	3.99e-05	0.000231	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—TPI1—Alzheimer's disease	3.95e-05	0.000229	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CHAT—Alzheimer's disease	3.95e-05	0.000229	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.91e-05	0.000226	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	3.8e-05	0.00022	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ENO1—Alzheimer's disease	3.8e-05	0.00022	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MAOB—Alzheimer's disease	3.78e-05	0.000219	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.77e-05	0.000219	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	3.73e-05	0.000216	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GAPDH—Alzheimer's disease	3.64e-05	0.000211	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—BCHE—Alzheimer's disease	3.53e-05	0.000205	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—A2M—Alzheimer's disease	3.52e-05	0.000204	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	3.52e-05	0.000204	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	3.33e-05	0.000193	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	3.23e-05	0.000187	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ACHE—Alzheimer's disease	3.06e-05	0.000177	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—INPP5D—Alzheimer's disease	3.03e-05	0.000175	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.97e-05	0.000172	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ENO1—Alzheimer's disease	2.87e-05	0.000166	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS1—Alzheimer's disease	2.87e-05	0.000166	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	2.81e-05	0.000163	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	2.79e-05	0.000161	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	2.77e-05	0.000161	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—BCHE—Alzheimer's disease	2.67e-05	0.000154	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—AKT1—Alzheimer's disease	2.54e-05	0.000147	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LPL—Alzheimer's disease	2.54e-05	0.000147	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLCB1—Alzheimer's disease	2.52e-05	0.000146	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ABCA1—Alzheimer's disease	2.44e-05	0.000141	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.43e-05	0.000141	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.43e-05	0.000141	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.33e-05	0.000135	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	2.28e-05	0.000132	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.24e-05	0.00013	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.17e-05	0.000126	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CALM1—Alzheimer's disease	2.13e-05	0.000124	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOE—Alzheimer's disease	2.13e-05	0.000123	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CAV1—Alzheimer's disease	2.11e-05	0.000122	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	2.1e-05	0.000122	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMOX1—Alzheimer's disease	2.09e-05	0.000121	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LPL—Alzheimer's disease	1.91e-05	0.000111	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.89e-05	0.000109	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.86e-05	0.000108	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARG—Alzheimer's disease	1.85e-05	0.000107	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—INS—Alzheimer's disease	1.82e-05	0.000105	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.77e-05	0.000102	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.77e-05	0.000102	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.73e-05	0.0001	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.72e-05	9.98e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.64e-05	9.52e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.61e-05	9.32e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOE—Alzheimer's disease	1.6e-05	9.29e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NOS3—Alzheimer's disease	1.59e-05	9.22e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.59e-05	9.21e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.55e-05	8.98e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.5e-05	8.7e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.46e-05	8.44e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.4e-05	8.09e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—INS—Alzheimer's disease	1.37e-05	7.94e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.29e-05	7.5e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.29e-05	7.47e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.2e-05	6.96e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.18e-05	6.83e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.1e-05	6.37e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.06e-05	6.15e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CALM1—Alzheimer's disease	9.92e-06	5.74e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOE—Alzheimer's disease	9.88e-06	5.72e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CAV1—Alzheimer's disease	9.79e-06	5.67e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARG—Alzheimer's disease	8.61e-06	4.99e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—INS—Alzheimer's disease	8.44e-06	4.89e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.4e-06	4.29e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AKT1—Alzheimer's disease	7.32e-06	4.24e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.77e-06	3.92e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AKT1—Alzheimer's disease	5.52e-06	3.2e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.4e-06	1.97e-05	CbGpPWpGaD
